Rare Disease

Latest News

Neoplasms, cancerous disease, malignant tumour | Ирина Батюк - stock.adobe.com
NCCN Guidelines Update Adds Momelotinib Below Ruxolitinib for High-, Low-Risk Myelofibrosis

January 23rd 2024

Momelotinib was given category 2A and 2B status for patients with high- and low-risk myelofibrosis (MF) and MF with anemia. However, ruxolitinib retains a higher category of recommendation as a treatment for patients with MF.

Top 5 Most-Read Rare Disease Articles of 2023
Top 5 Most-Read Rare Disease Articles of 2023

December 29th 2023

sickle cell disease | Image credit: Dr_Microbe - stock.adobe.com
Interventions Needed to Increase DMT Uptake in Sickle Cell Disease

December 26th 2023

Polycythemia vera, a rare slow-growing blood cancer with an increase in the number of red blood cells | Dr_Microbe - stock.adobe.com
Age-Adjusted Index, Machine Learning Are Significant Factors for Predicting Thrombosis in Polycythemia Vera

December 18th 2023

Matthew Frigault, MD, MS, Harvard Medical School, Massachusetts General Hospital Cancer Center
Novel BCMA-Directed CAR Anito-Cel Is Highly Effective for Myeloma

December 12th 2023

More News

CH LogoCenter for Biosimilars Logo